BM-MSC Exosomes Modulate TUG1, Fight Leukemia
In a groundbreaking study published in Medical Oncology, researchers have unveiled the promising therapeutic potential of bone marrow-derived mesenchymal stem cell (BM-MSC) exosomes in modulating the oncogenic long non-coding RNA…







